Effectiveness of Cortisone Injection and Splinting for Trigger Finger
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
Trigger finger has a prevalence rate of up to 3%. There are many approaches available to
manage this condition. While corticosteroid injection is widely accepted as the most common
first-line treatment, its superiority over splint treatment has not been established. This
study aims to test the effectiveness of cortisone injections, splint and cortisone+splint to
resolve symptoms.